The United States Food and Drug Administration and Prescription Drug Promotion
نویسندگان
چکیده
منابع مشابه
Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration
The volume of prescription drug promotion over time is often measured by assessing changes in ad spending. However, this method obscures the fact that some types of advertising are more expensive than others. Another way to measure the changes in prescription drug promotion over time is to assess the number of promotional pieces submitted to the U.S. Food and Drug Administration (FDA). Form FDA...
متن کاملData from the United States Food and Drug Administration.
BACKGROUND In the US, manufacturers seeking approval to market a generic drug product must submit data demonstrating that the generic formulation provides the same rate and extent of absorption as (ie, is bioequivalent to) the innovator drug product. Thus, most orally administered generic drug products in the US are approved based on results of one or more clinical bioequivalence studies. OBJ...
متن کاملUnited States Food and Drug Administration seeks global regulatory regime.
Administration (FDA) is proposing to develop and lead a more coordinated global approach to the inspection and monitoring of foods, drugs and medical devices. Globalization is forcing the development of a more coordinated international approach to regulation of such products, much as it affected the rapid spread of infectious diseases and the need for global responses in the area of public heal...
متن کاملUnited States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.
On May 5, 2003, gefitinib (Iressa; ZD1839) 250-mg tablets (AstraZeneca Inc.) received accelerated approval by the United States Food and Drug Administration as monotherapy for patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies. Information provided in this summary includes chemistry manufacturing and controls...
متن کاملPharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
STUDY OBJECTIVES To review the labels of United States Food and Drug Administration (FDA)-approved drugs to identify those that contain pharmacogenomic biomarker information, and to collect prevalence information on the use of those drugs for which pharmacogenomic information is included in the drug labeling. DESIGN Retrospective analysis. DATA SOURCES The Physicians' Desk Reference Web sit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Innovations in Cardiac Rhythm Management
سال: 2019
ISSN: 2156-3977,2156-3993
DOI: 10.19102/icrm.2019.100305